These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 35585641

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India.
    Ahmad SS, Verma R, Commons RJ, Nitika, Singh-Phulgenda S, Chhajed R, Bharti PK, Behera B, Naser SM, Pal SK, Ranjit PH, Baharia RK, Solanki B, Upadhyay KJ, Guerin PJ, Sharma A, Price RN, Rahi M, Thriemer K.
    Trials; 2024 Feb 29; 25(1):154. PubMed ID: 38424577
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens.
    IMPROV Study Group.
    BMC Infect Dis; 2015 Dec 07; 15():558. PubMed ID: 26643116
    [Abstract] [Full Text] [Related]

  • 7. Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment.
    Woon SA, Moore BR, Laman M, Tesine P, Lorry L, Kasian B, Yambo P, Yadi G, Pomat W, Batty KT, Salman S, Robinson LJ, Davis TME, Manning L.
    Int J Infect Dis; 2023 May 07; 130():189-195. PubMed ID: 36906121
    [Abstract] [Full Text] [Related]

  • 8. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
    Taylor WRJ, Thriemer K, von Seidlein L, Yuentrakul P, Assawariyathipat T, Assefa A, Auburn S, Chand K, Chau NH, Cheah PY, Dong LT, Dhorda M, Degaga TS, Devine A, Ekawati LL, Fahmi F, Hailu A, Hasanzai MA, Hien TT, Khu H, Ley B, Lubell Y, Marfurt J, Mohammad H, Moore KA, Naddim MN, Pasaribu AP, Pasaribu S, Promnarate C, Rahim AG, Sirithiranont P, Solomon H, Sudoyo H, Sutanto I, Thanh NV, Tuyet-Trinh NT, Waithira N, Woyessa A, Yamin FY, Dondorp A, Simpson JA, Baird JK, White NJ, Day NP, Price RN.
    Lancet; 2019 Sep 14; 394(10202):929-938. PubMed ID: 31327563
    [Abstract] [Full Text] [Related]

  • 9. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S, Pradines B, Basco LK.
    Bull Soc Pathol Exot; 2017 Aug 14; 110(3):198-206. PubMed ID: 28417346
    [Abstract] [Full Text] [Related]

  • 10. Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.
    Kheng S, Muth S, Taylor WR, Tops N, Kosal K, Sothea K, Souy P, Kim S, Char CM, Vanna C, Ly P, Ringwald P, Khieu V, Kerleguer A, Tor P, Baird JK, Bjorge S, Menard D, Christophel E.
    BMC Med; 2015 Aug 25; 13():203. PubMed ID: 26303162
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    Devine A, Battle KE, Meagher N, Howes RE, Dini S, Gething PW, Simpson JA, Price RN, Lubell Y.
    PLoS Med; 2021 Jun 25; 18(6):e1003614. PubMed ID: 34061843
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
    Milligan R, Daher A, Villanueva G, Bergman H, Graves PM.
    Cochrane Database Syst Rev; 2020 Aug 19; 8():CD012656. PubMed ID: 32816320
    [Abstract] [Full Text] [Related]

  • 15. Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan.
    Hamid MMA, Thriemer K, Elobied ME, Mahgoub NS, Boshara SA, Elsafi HMH, Gumaa SA, Hamid T, Abdelbagi H, Basheir HM, Marfurt J, Chen I, Gosling R, Price RN, Ley B.
    Malar J; 2018 Mar 16; 17(1):117. PubMed ID: 29548285
    [Abstract] [Full Text] [Related]

  • 16. The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR.
    Phommasone K, van Leth F, Imwong M, Henriques G, Pongvongsa T, Adhikari B, Peto TJ, Promnarate C, Dhorda M, Sirithiranont P, Mukaka M, Peerawaranun P, Day NPJ, Cobelens F, Dondorp AM, Newton PN, White NJ, von Seidlein L, Mayxay M.
    Malar J; 2020 Jan 03; 19(1):4. PubMed ID: 31900172
    [Abstract] [Full Text] [Related]

  • 17. Plasmodium vivax in the Era of the Shrinking P. falciparum Map.
    Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K.
    Trends Parasitol; 2020 Jun 03; 36(6):560-570. PubMed ID: 32407682
    [Abstract] [Full Text] [Related]

  • 18. Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis.
    Rajasekhar M, Simpson JA, Ley B, Edler P, Chu CS, Abreha T, Awab GR, Baird JK, Bancone G, Barber BE, Grigg MJ, Hwang J, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Llanos-Cuentas A, Pukrittayakamee S, Rijal KR, Saravu K, Sutanto I, Taylor WRJ, Thriemer K, Watson JA, Guerin PJ, White NJ, Price RN, Commons RJ, WorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group.
    Lancet Infect Dis; 2024 Feb 03; 24(2):184-195. PubMed ID: 37748497
    [Abstract] [Full Text] [Related]

  • 19. Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.
    Nelwan EJ, Ekawati LL, Tjahjono B, Setiabudy R, Sutanto I, Chand K, Ekasari T, Djoko D, Basri H, Taylor WR, Duparc S, Subekti D, Elyazar I, Noviyanti R, Sudoyo H, Baird JK.
    BMC Med; 2015 Dec 11; 13():294. PubMed ID: 26654101
    [Abstract] [Full Text] [Related]

  • 20. Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam.
    Pham TV, Nguyen HV, Aguirre AR, Nguyen VV, A Cleves M, Nguyen XX, Nguyen TT, Tran DT, Le HX, Hens N, Rosanas-Urgell A, D'Alessandro U, Speybroeck N, Erhart A.
    PLoS Med; 2019 May 11; 16(5):e1002784. PubMed ID: 31100064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.